Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility

Executive Summary

• Canopy Growth’s DOJA facility in Kelowna, BC is now operating exclusively as a medical‑cultivation site for the Spectrum Therapeutics portfolio.
• The site will produce small‑batch, craft‑quality cannabis under the DOJA brand, sold only to registered Spectrum Therapeutics patients, including Canada’s veteran community.
• The transition utilizes a new micro‑cultivation licence and supports product development and consistent high‑quality supply for Spectrum’s medical offerings.

Key Details

• Facility conversion: Kelowna DOJA site upgraded and re‑licensed as a micro‑cultivation operation dedicated to medical cannabis.
• Product focus: Small‑batch, BC‑grown craft cannabis under the DOJA brand, exclusive to Spectrum Therapeutics patients.
• Target market: Registered Spectrum Therapeutics medical patients across Canada, with special emphasis on veteran patients.
• Strategic rationale: Enhances Canopy Growth’s commitment to Canada’s medical cannabis market and strengthens Spectrum Therapeutics’ leadership in that segment.
• Leadership comments:
• Luc Mongeau (CEO) highlighted the move as evidence of a “long‑term commitment to medical cannabis” and a focus on building a sustainable Canadian business.
• Andrew Bevan (SVP, Global Medical) described DOJA as a “distinct commercial opportunity” that reinforces Spectrum’s portfolio.
• Patient access: Registered patients can obtain information on available DOJA flower strains via www.spectrumtherapeutics.com.

Notable Quotes

“As we advance Canopy Growth’s transformation, Canada’s medical market continues to be a standout business for us,” – Luc Mongeau, Chief Executive Officer.

“DOJA represents a distinct commercial opportunity for Canopy Growth’s Canadian medical business… enhances our portfolio and reinforces Spectrum’s leadership in Canada’s medical market.” – Andrew Bevan, SVP, Global Medical.